Skip to main content
. 2013 Aug 5;72(12):1897–1904. doi: 10.1136/annrheumdis-2013-203485

Figure 1.

Figure 1

Characterisation of rheumatoid arthritis (RA) patient subpopulations for whom biologic monotherapy may be considered. AE, adverse event; MTX, methotrexate.